OP
RVMD icon

ORG Partners’s Revolution Medicines RVMD Stock Holding History

ORG Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.19K Hold
15
– – ﹤0.01% 1519
2025
Q3 		$700 Hold
15
– – ﹤0.01% 1433
2025
Q2 		$553 Hold
15
– – ﹤0.01% 1396
2025
Q1 		$504 Buy
+15
New +$609 ﹤0.01% 1272

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

ORG Partners's RVMD Position: Q4 2025 in Review

ORG Partners held its Revolution Medicines (RVMD) position steady in Q4 2025 at 15 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

ORG Partners first reported a position in RVMD in Q1 2025 and has held it in 4 quarters since. 386 funds tracked by Wall St. Rank hold RVMD as of Q4 2025.

  • ORG Partners held 15 shares of Revolution Medicines worth $1.19K as of Q4 2025.
  • ORG Partners left its Revolution Medicines share count unchanged in Q4 2025.
  • Revolution Medicines made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1519 holding.
  • ORG Partners first reported a position in Revolution Medicines in Q1 2025 and has held it in 4 quarters since.
  • 386 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.